pd 145065 has been researched along with saralasin in 1 studies
Studies (pd 145065) | Trials (pd 145065) | Recent Studies (post-2010) (pd 145065) | Studies (saralasin) | Trials (saralasin) | Recent Studies (post-2010) (saralasin) |
---|---|---|---|---|---|
76 | 1 | 5 | 1,497 | 13 | 16 |
Protein | Taxonomy | pd 145065 (IC50) | saralasin (IC50) |
---|---|---|---|
Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0017 | |
Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0017 | |
Type-1 angiotensin II receptor | Homo sapiens (human) | 0.0006 | |
Type-2 angiotensin II receptor | Homo sapiens (human) | 0.0008 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Calaghan, SC; White, E | 1 |
1 other study(ies) available for pd 145065 and saralasin
Article | Year |
---|---|
Contribution of angiotensin II, endothelin 1 and the endothelium to the slow inotropic response to stretch in ferret papillary muscle.
Topics: Angiotensin II; Animals; Endothelin-1; Endothelium; Female; Ferrets; Kinetics; Losartan; Male; Muscle Spindles; Myocardial Contraction; Octoxynol; Oligopeptides; Papillary Muscles; Peptides, Cyclic; Saralasin | 2001 |